CLINICAL EXPERIENCES OF TYPE 2 DIABETES (T2DM) PATIENTS INITIATING ORAL SEMAGLUTIDE

被引：0
|
作者：
Dunn, T. J. [1 ]
Swift, C. [1 ]
Guesnier, A. [1 ]
Noone, J. [1 ]
Willey, V [2 ]
机构：
[1] Novo Nordisk Inc, Plainsboro, NJ USA
[2] HealthCore Inc, Wilmington, DE USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO30
引用
收藏
页码：S309 / S309
页数：1
相关论文
共 50 条
  • [1] CHANGES IN DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES (T2DM) INITIATING SUBCUTANEOUS SEMAGLUTIDE
    Dunn, T. J.
    Swift, C.
    Guesnier, A.
    Noone, J.
    Willey, V
    VALUE IN HEALTH, 2022, 25 (07) : S321 - S321
  • [2] MEDICATION UTILIZATION PATTERNS AMONG T2DM PATIENTS INITIATING TREATMENT WITH ORAL SEMAGLUTIDE
    Frazer, M.
    Swift, C.
    Sargent, A.
    Leszko, M.
    Buysman, E. K.
    Alvarez, S.
    Noone, J.
    Guevarra, M.
    VALUE IN HEALTH, 2023, 26 (06) : S255 - S255
  • [3] Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin
    Martin, Silas C.
    Henk, Henry J.
    Chow, Wing
    DIABETES, 2014, 63 : A307 - A307
  • [4] MEDICATION USE AMONG T2DM PATIENTS INITIATING TREATMENT WITH ONCE WEEKLY (OW) SEMAGLUTIDE
    Frazer, M.
    Swift, C.
    Sargent, A.
    Leszko, M.
    Buysman, E. K.
    Alvarez, S.
    Noone, J.
    Gamble, C.
    VALUE IN HEALTH, 2023, 26 (06) : S246 - S246
  • [5] ADHERENCE AND PERSISTENCE IN PATIENTS INITIATING TREATMENT WITH INJECTABLE THERAPIES FOR TYPE 2 DIABETES MELLITUS (T2DM) IN SPAIN
    Sicras-Mainar, A.
    Navarro, R.
    Ruiz, L.
    Morano, R.
    VALUE IN HEALTH, 2015, 18 (07) : A612 - A612
  • [6] Preference and Propensity: Evaluating Oral Treatment of Type 2 Diabetes (T2DM)
    Ritchey, Mary E.
    Chen, Yong
    Girman, Cynthia J.
    Brodovicz, Kimberly G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 199 - 200
  • [7] Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes (T2DM)
    Kohler, Sven
    Salsali, Afshin
    Hantel, Stefan
    Kim, Gabriel
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2015, 64 : A302 - A303
  • [8] Albuminuria and the prediction of retinopathy in patients with type 2 diabetes (T2DM)
    Inzucchi, SE
    Chyun, DA
    Young, LH
    Davey, JA
    Wittlin, SD
    Grey, NJ
    Wackers, FJT
    DIABETES, 2005, 54 : A558 - A559
  • [9] Treatment Persistence and Switch in German Patients with Type 2 Diabetes Mellitus (T2DM) after Initiating Basal Insulin
    Chou, Engels
    Dippel, Franz-Werner
    Chung, Hsing-Wen
    DIABETES, 2014, 63 : A403 - A403
  • [10] Diabetic Gastroparesis: Comparison of Clinical Features in Patients with Type 2 (T2DM) and Type 1 (T1DM) Diabetes Mellitus
    Koch, Kenneth
    Hasler, William
    Calles, Jorge
    Parkman, Henry
    Pasricha, Pankaj
    Abell, Thomas
    Snape, William
    Colvin, Ryan
    Tonascia, James
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S56 - S56
12345